| 02/12/22 | Eli Lilly : a finalisé l'acquisition d'Akouos | |
| 01/12/22 | Eli Lilly : vers l'acquisition de 81.1% des actions d'Akouos | |
| 19/10/22 | Wall Street sluit hoger | |
| 19/10/22 | Wall Street houdt winst vast | |
| 19/10/22 | MÄRKTE USA/Börsen setzen Erholung fort |
| 1 day | +1.06% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 43 | 01/01/2016 | |
Jean Phillips
CTO | Chief Tech/Sci/R&D Officer | - | - |
Aaron Tward
CTO | Chief Tech/Sci/R&D Officer | - | 10/03/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Jean Bennett
BRD | Director/Board Member | 71 | 01/01/2018 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 1/12/22 | Issuer sale | Director | 16,000 | 0.0433% | ||
| 1/12/22 | Issuer sale | Director | 55,030 | 0.1489% | ||
| 1/12/22 | Issuer sale | Chief Financial Officer | 150,000 | 0.4060% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.06% | +0.91% | - | - | 491M | |
| -0.81% | -0.33% | +27.15% | +81.12% | 55.23B | |
| +2.17% | -5.17% | +28.33% | +66.91% | 53.75B | |
| -0.11% | +0.86% | -15.63% | -13.56% | 23.48B | |
| -1.58% | -5.51% | -3.51% | +375.36% | 22B | |
| +2.49% | -0.92% | +20.31% | -12.15% | 19.78B | |
| +0.41% | -1.81% | +28.31% | -33.82% | 17.44B | |
| +0.58% | -5.88% | +16.30% | +540.37% | 14.66B | |
| +1.16% | +0.58% | +51.87% | +181.96% | 14.07B | |
| -5.09% | -10.87% | +153.11% | +272.20% | 13.02B | |
| Average | +0.03% | -1.55% | +34.03% | +162.04% | 25.94B | |
| Weighted average by Cap. | +0.21% | -0.44% | +27.57% | +125.14% |
Employees
103
